Glox Therapeutics in a £4.3M seed round of funding led by Boehringer Ingelheim Venture Fund (BIVF) and Scottish Enterprise.

Biotech Health services Pharma

Investments

04 November 2023

Glox Therapeutics (company)

Biotech Health services Pharma

Total investments received (USD): 5.25m

Round value (USD): 5.25m

Round investors: Boehringer Ingelheim Venture Fund Scottish Enterprise

Industry: Biotech Health services Pharma

Health services Manufacturing Pharma

Investments 13 April 2024

Biotech Hardware Health services Manufacturing Software Services

Investments 03 April 2024

Biotech Hardware Health services Manufacturing

Investments 01 April 2024

Biotech Health services Manufacturing

Investments 08 March 2024

Biotech Health services Manufacturing Pharma Software Services

Investments 17 February 2024